Watch Ticker

Replimune Group, Inc.

Go to Replimune Group, Inc. Website

$6.30

0.59 (10.33%)

Live

Previous Close

$5.71

Day Range

$5.67 - $6.39

Previous Day Range

$5 - $5.8

Market Cap

$591.3 million USD

Day Vol.

8.1 million

Previous Day Vol.

22.3 million

Currency

USD

Primary Exchange

Nasdaq

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rosen Law Firm - ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPL

Rosen Law Firm is investigating a securities class action against Replimune Group regarding allegedly false statements about the IGNYTE trial's prospects, which the FDA deemed inadequate.

Related tickers: REPL.

Read Full Article

Wolf Haldenstein Adler Freeman & Herz Llp - Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd

A securities class action lawsuit has been filed against Replimune Group after the FDA rejected its Biologics License Application for RP1, causing a significant stock price drop of 77.24%.

Related tickers: REPL.

Read Full Article

Trending Tickers

Please sign in to view